BRUNELLO, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 9150
EU - Europa 5044
AS - Asia 454
OC - Oceania 20
SA - Sud America 20
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 14706
Nazione #
US - Stati Uniti d'America 9088
GB - Regno Unito 1458
DE - Germania 1376
IT - Italia 665
SE - Svezia 616
UA - Ucraina 207
RU - Federazione Russa 206
CN - Cina 184
BG - Bulgaria 161
TR - Turchia 133
IE - Irlanda 89
FI - Finlandia 81
FR - Francia 75
IN - India 56
CA - Canada 51
BE - Belgio 36
AU - Australia 19
CH - Svizzera 14
HK - Hong Kong 12
VN - Vietnam 12
RO - Romania 11
BR - Brasile 10
JP - Giappone 10
NL - Olanda 10
ES - Italia 8
IR - Iran 8
PL - Polonia 8
EG - Egitto 6
MX - Messico 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CL - Cile 5
PK - Pakistan 5
TH - Thailandia 5
GR - Grecia 4
ID - Indonesia 4
SG - Singapore 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
DK - Danimarca 3
EU - Europa 3
KZ - Kazakistan 3
MY - Malesia 3
AN - Antille olandesi 2
BZ - Belize 2
HU - Ungheria 2
IL - Israele 2
KR - Corea 2
LT - Lituania 2
MD - Moldavia 2
MK - Macedonia 2
TW - Taiwan 2
AT - Austria 1
BD - Bangladesh 1
CO - Colombia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
HT - Haiti 1
IQ - Iraq 1
KH - Cambogia 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SD - Sudan 1
Totale 14706
Città #
Fairfield 1547
Southend 1246
Chandler 1006
Woodbridge 808
Houston 638
Ashburn 528
Wilmington 528
Cambridge 469
Seattle 429
Jacksonville 422
Nyköping 400
Dearborn 321
Ann Arbor 314
Modena 249
San Diego 201
Princeton 181
Sofia 161
Dublin 87
Eugene 76
Beijing 74
London 66
Izmir 65
Des Moines 57
Falls Church 48
Fremont 44
Redwood City 41
Brussels 33
Norwalk 33
Bremen 27
Milan 27
San Mateo 23
Nanjing 18
Toronto 18
Helsinki 17
Bologna 15
Boardman 12
Hefei 12
Rome 12
San Giuliano Milanese 12
Catania 10
Chicago 10
Ottawa 10
San Francisco 10
Vancouver 10
Verona 10
Dong Ket 9
Kunming 9
Liebefeld 9
Auburn Hills 8
Guangzhou 8
Sydney 8
Central District 7
Leawood 7
Phoenix 7
Augusta 6
Indiana 6
Istanbul 6
Paris 6
Ardabil 5
Florence 5
Islington 5
Jinan 5
Konya 5
Los Angeles 5
Mumbai 5
New York 5
Reggio Emilia 5
Shanghai 5
Zhengzhou 5
Amsterdam 4
Bari 4
Buffalo 4
Chengdu 4
Clearwater 4
Como 4
Fuzhou 4
Hebei 4
Kemerovo 4
Mountain View 4
Parma 4
San Jose 4
Tulare 4
Wuhan 4
Almaty 3
Andover 3
Bangkok 3
Brescia 3
Bursa 3
Cairo 3
Casalgrande 3
Centro 3
Ecatepec 3
Gdansk 3
Groningen 3
Horia 3
Las Vegas 3
Lodi 3
Maser 3
Melbourne 3
Mitoma 3
Totale 10583
Nome #
N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons. 275
Disease-induced neuroinflammation and depression 274
Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment 258
Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain 239
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 223
Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain 219
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in a rat model of depression 217
P.2.a.012 Co-administration of fluoxetine with acetylsalicylic acid, but not flurbiprofen or celecoxib, for one week shows an antidepressant-like effect 211
Hypothalamic expression of inflammatory mediators in an animal model of binge eating 211
Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells 206
Molecular changes associated with escitalopram response in a stress-based model of depression 206
Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 206
Erratum to: Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 (J Neuroimmune Pharmacol, 2015, DOI 10.1007/s11481-015-9641-x) 205
Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress 201
Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment 198
Neonatal persistent inflammation alters pain response and NMDA receptor expression in adult mice 196
Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression 195
Chronic antidepressant treatments resulted in altered expression of genes involved in inflammation in the rat hypothalamus 193
Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. 192
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 188
Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats 188
Lymnaea stagnalis as model for translational neuroscience research: from pond to bench 186
Early neonatal inflammation affects adult pain reactivity and anxiety related traits in mice: genetic background counts 183
Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype 181
Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine 181
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression 179
Interferon alpha exposure increases the expression of the enzymes belonging to the kynurenine pathway in an in vitro model of human neurons: SH-SY5Y cells 176
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study 175
Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function. 174
Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases 169
Effects of acute stress on brain-derived neurotrophic factor in the hippocampus of transgenic mouse model of depression 168
HTR1B as a risk profile maker in psychiatric disorders:a review through motivation and memory 167
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 164
Early postnatal chronic inflammation produces long-term changes in pain behavior and N-methyl-D-aspartate receptor subtype gene expression in the central nervous system of adult mice 159
Cognitive deficits and changes in gene expression of NMDA receptors after prenatal methylmercury exposure 157
Modulation of neuroplasticity-related targets following stress-induced acute escape deficit 157
P.1.04 Expression of histone variants H3.3 and H2a.z in the rat brain: Physiopathological and pharmacological implications 157
Impaired stress-induced regulation of brain derived neurotrophic factor expression in hippocampus of glucocorticoid receptor impaired mice: Model of depression 156
Behavioural and molecular effects of the combined treatment fluoxetine plus acetylsalicylic acid in a rat model of depression 155
Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders 154
Cloning of mouse Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKKbeta) and characterization of CaMKKbeta and CaMKKalpha distribution in the adult mouse brain. 154
Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKK alpha and CaMKK beta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor 151
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 151
Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain 149
Neither all anti-inflammatory drugs nor all doses are effective in accelerating the antidepressant-like effect of fluoxetine in an animal model of depression 149
Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria 148
Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 145
Regulation of CREB function in rat frontal cortex after combined treatment with Fluoxetine and Olanzapine 145
Mood stabilizers: protecting the mood ... protecting the brain 143
New combination therapies from animal to human 143
Gene expression profile of the hippocampus of a behavioural model of depression 143
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 140
Interferon-alpha exposure increases the expression of enzymes of the kynurenine pathway and induces apoptosis in a model of human neurons 137
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas 134
Restraint stress increases the expression of brain derived neurotrophic factor in the hippocampus of a mouse model of depression 133
Cyclic GMP inhibition of metabotropic glutamate receptor-induced phosphoinositide hydrolysis in mesencephalic neurons 130
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression 129
Molecular effects of subchronic andchronic treatment with escitalopram inthe rat central nervous system 129
Combined effect of antidepressant and anti-inflammatory drugs in an animal model of depressio 129
Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate). . 128
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment 124
Interplay between inflammation and neural plasticity: Both immune activation and suppression impair LTP and BDNF expression 121
cAMP-dependent phosphorylation system after short and long-term administration of moclobemide 120
Metabolic characterization of SH-SY5Y cells and effects of interferon-alpha exposure 119
Combined fluoxetine and metformin treatment potentiates antidepressant efficacy increasing IGF2 expression in the dorsal hippocampus 119
Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment 118
Practical issues in clinical research of schizophrenia 117
Effect of idebenone on in vivo serotonin release and serotonergic receptors in young and aged rats 117
Metabolic changes induced by interferon-α exposure in an in vitro model of human neurons 110
Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress 103
New insights into the biology of schizophrenia through the mechanism of action of clozapine. 99
Chiralità e farmaci antidepressivi 98
Serum metabolic signature of binge-like palatable food consumption in female rats by nuclear magnetic resonance spectroscopy 98
Escitalopram: meccanismo d’azione e profili clinico 97
Second messenger-regulated protein kinases in the brain: Their functional role and the action of antidepressant drugs 94
Vortioxetine Prevents Lipopolysaccharide-Induced Memory Impairment Without Inhibiting the Initial Inflammatory Cascade 88
Hippocampus-related effects of fluoxetine treatment under stressful vs enriched conditions 82
Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit NMDA receptor activity and prevent neurotoxicity in mesencephalic neuron in vitro 79
Deciphering the central immunomodulatory effects of a vortioxetine pretreatment on the LPS-induced inflammatory cascade 79
P.304 Executive functioning and genetic variation in pediatric patients with cancer 76
Farmacologia e neurobiologia nei disturbi d'ansia e nella depressione 59
Age‐Related Changes in Rat Serotonergic and Adrenergic Systems and in Receptor Responsiveness to Subchronic Desipramine Treatment 48
Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: Dissociation from effects on prolactin secretion 46
Posttraumatic stress disorder: Diagnosis and epidemiology, comorbidity and social consequences, biology and treatment 45
Behavioural and neurochemical changes produced by lefetamine in two inbred strains of mice 45
Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rats: Interactions with reserpine 44
Behavioural and biochemical effects in C57BL/6J mice after a prolonged treatment with the δ‐opiate antagonist ICI 154129 44
The activity of some neurotransmitter-synthetizing enzymes in experimental cobalt epilepsy 43
Biochemical and behavioral changes in rats after prolonged treatment with desipramine: interaction with p-chlorophenylalanine 41
Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioural and biochemical studies 40
Age-related changes in 5HT uptake and [3H]imipramine binding sites in rat cerebral cortex 40
Effects of an extract of Ginkgo Biloba on noradrenergic systems of rat cerebral cortex 40
cAMP-dependent binding proteins and endogenous phosphorylation after antidepressant treatment 39
cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity 37
Serine/threonine kinases as molecular targets of antidepressants: Implications for pharmacological treatment and pathophysiology of affective disorders 37
cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment 37
International Academy for Biomedical and Drug Research Consensus Conference, San Juan, December 8-9, 1996: Novel therapeutic indications of antidepressant drugs: Introduction 36
Environmental enrichment influences mouse hippocampal neuroinflammatory response 35
Different adaptive responses by rat striatal dopamine synthetic and receptor mechanisms after repeated treatment with d-amphetamine, methylphenidate and nomifensine 35
Totale 13404
Categoria #
all - tutte 39055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39055

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201859 0000 00 00 00059
2018/20191790 641076398 110101 13545 132176376383
2019/20202929 22916086135 288450 478318 26895264158
2020/20212805 40387237263 278224 201286 171310214131
2021/20223237 451248153239 75224 111135 298337664302
2022/20232742 295251238280 279431 51309 4333712018
Totale 15010